Intragenic amplification of PAX5: a novel subgroup in B-cell precursor acute lymphoblastic leukemia?
Claire Schwab,Karin Nebral,Lucy Chilton, Cristina Leschi,Esmé Waanders,Judith M Boer,Markéta Žaliová,Rosemary Sutton,Ingegerd Ivanov Öfverholm,Kentaro Ohki,Yuka Yamashita,Stefanie Groeneveld-Krentz,Eva Froňková,Marleen Bakkus,Joelle Tchinda,Thayana da Conceição Barbosa,Grazia Fazio,Wojciech Mlynarski,Agata Pastorczak,Giovanni Cazzaniga,Maria S Pombo-de-Oliveira,Jan Trka,Renate Kirschner-Schwabe,Toshihiko Imamura,Gisela Barbany,Martin Stanulla,Andishe Attarbaschi,Renate Panzer-Grümayer,Roland P Kuiper,Monique L den Boer,Hélène Cavé,Anthony V Moorman,Christine J Harrison,Sabine Strehl Blood advances(2017)
摘要
Intragenic PAX5 amplification defines a novel, relapse-prone subtype of B-cell precursor acute lymphoblastic leukemia with a poor outcome.
更多查看译文
AI 理解论文
溯源树
样例